Artiva Biotherapeutics, Inc. (ARTV) vs Cabaletta Bio, Inc. (CABA)

Artiva Biotherapeutics, Inc. and Cabaletta Bio, Inc. are both Biotechnology companies. Artiva Biotherapeutics, Inc. and Cabaletta Bio, Inc. are of similar size ($373.0M and $366.2M). Across the 8 metrics below, Artiva Biotherapeutics, Inc. leads on 7 and Cabaletta Bio, Inc. on 1.

Valuation

Metric ARTV CABA Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.79 1.49 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.79 n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (47.21%) (75.85%) (28.84%)
Free cash flow yield (27.92%) (49.59%) (23.03%)

Profitability

Metric ARTV CABA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (36.58%) (93.20%) (57.72%)
Return on assets (33.76%) (75.36%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARTV CABA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 40.96% 10.26% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ARTV CABA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 24.16 5.79 4.73
Net debt to EBITDA 1.24 0.84 0.96

Dividend

Metric ARTV CABA Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric ARTV CABA Biotechnology median
Market cap 366.19m 373.00m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack